C25 BioTelemetry Inc.

BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020

BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020

MALVERN, Pa., April 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2020 earnings on Wednesday, May 6 at 4:00 PM Eastern Time.

The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 6, 2020.  The broadcast will be available through the investor information section of the BioTelemetry website .  If you are unable to participate during the live webcast, an archive will be available on the website for two weeks.

About BioTelemetry

BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care.  We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing that serves both healthcare and clinical research customers.  More information can be found at . 

Contact:BioTelemetry, Inc.
 Heather C. Getz
 Investor Relations
 Executive Vice President, Chief Financial Officer
 800-908-7103
  

EN
29/04/2020

Underlying

C25BioTelemetry Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BioTelemetry Inc.

Free Trial
C25 BioTelemetry I...

Heartbeam Inc: 1 director

A director at Heartbeam Inc sold after exercising options/sold 57,146 shares at 2.830USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...

C25 BIOTELEMETRY INC.
11h / 32m 11h / 32m 1 EN
 PRESS RELEASE
Free
C25 BioTelemetry I...

Philips to Acquire BioTelemetry

Philips to Acquire BioTelemetry Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion)Acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient monitoring position in the hospital with BioTelemetry’s leading cardiac diagnostics and monitoring position outside the hospitalWith 2019 sales of USD 439 million, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, AI-based data an...

December 18, 2020 1 EN
 PRESS RELEASE
Free
C25 BioTelemetry I...

BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results

BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results Posts Record Quarterly Revenue Amidst Rapid Recovery MALVERN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended September 30, 2020. Quarter Highlights Recognized quarterly total revenue of $114.7 millionReached 3.0% year-over-year quarterly revenue growth, despite the impact of COVID-19Reported quarterly GAAP net...

October 29, 2020 1 EN
MarketLine Department
  • MarketLine Department
EUR 298.83
C25 BioTelemetry I...
VPT Ventripoint Dia... ... (+3)

CardioComm Solutions, Inc. - Mergers & Acquisitions (M&A), Partnership...

Summary Marketline's CardioComm Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CardioComm Solutions, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdow...

C25 BIOTELEMETRY INC.
VPT VENTRIPOINT DIAGNOSTICS LTD
ZMD ZOOMMED INC
10/29/20 October 29, 2020 132 EN
 PRESS RELEASE
Free
C25 BioTelemetry I...

BioTelemetry, Inc. to Release Third Quarter 2020 Earnings Results on O...

BioTelemetry, Inc. to Release Third Quarter 2020 Earnings Results on October 29, 2020 MALVERN, Pa., Oct. 22, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time. BioTelemetry, Inc. will host an earnings conference call on Thursday, October 29, at 5:00 PM Eastern Time.  The call will be webcast on the investor information page of our website, .  The call will be archived on our website for at least two weeks. About BioTelemetryBioTelemetry, Inc. is the leading remote medical technology comp...

October 22, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch